Vimarsana
Biggest News Aggregation in the World

Page 6 - Scientific Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Session Today - Breaking & Trending Today

One on One ... with Curtis P. Langlotz, MD, PhD - Vimarsana News

One on One ... with Curtis P. Langlotz, MD, PhD

Stanford University Professor of Radiology, Medicine and Biomedical Data Science; Director of the Center for Artificial Intelligence in Medicine and  Imaging (AIMI Center); Associate Director of Stanford’s Institute for Human-Centered Artificial Intelligence (HAI); and Associate Chair for Information Systems, Medical Informatics Director for Stanford Health Care  

Top 5 Most-Read PAH Content of 2023 - Vimarsana News

Top 5 Most-Read PAH Content of 2023

This year’s top 5 most-read articles on pulmonary arterial hypertension (PAH) explored expert opinions on treatment approaches, data on newly emerging therapies, the impacts of alcohol, and more.

Source: ajmc.com
ICYMI: Highlights From ACC 2023 - Vimarsana News

ICYMI: Highlights From ACC 2023

Our top coverage from the 72nd American College of Cardiology (ACC) Scientific Session included results from the STELLAR, CLEAR Outcomes, ACCESS, and HALO trials.

Source: ajmc.com
New AHA 23 Data Further Highlights Role of Inflammation in Cardiovascular Risk - Vimarsana News

New AHA 23 Data Further Highlights Role of Inflammation in Cardiovascular Risk

Paul Ridker, MD, MPH, discusses the evolving recognition of the role inflammation plays in driving cardiovascular risk among patients with atherosclerosis.

Argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions - Vimarsana News

Argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions

Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression in generalized myasthenia...